Weight loss injection could decrease risk of heart attack

The benefits to weight loss injections continues to grow!

Ongoing studies show that obesity jabs could reduce the risk of strokes and heart attacks even if patients do not lose significant weight.

Semaglutide (Wegovy) could improve and ‘benefit the cardiovascular health of millions of adults.’ https://www.bbc.co.uk/news/articles/cd188m73vn1o#:~:text=Obesity%20jabs%20could%20cut%20the,funded%20by%20a%20drug%20manufacturer

UCL’s ongoing study and findings were discussed at the European Congress on Obesity, and suggested that ‘even people with mild obesity or those not losing weight are likely to gain some cardiovascular advantage.’ UCL’s online report goes on to explain that this medication may have beneficial effects on blood sugar levels, blood pressure, and inflammation, whilst also directly improving the heart muscle, blood vessels, or a combination of these factors. https://www.ucl.ac.uk/news/2024/may/weight-loss-drug-semaglutide-linked-better-heart-health

Research shows that by using weight loss injections, you are improving your physical body, but also potentially improving your inner health and heart.

With the benefits to weight loss injections continuing to increase – why don’t you fill out our medication’s health questionnaire, or contact us today to start your weight loss journey!

SELECT trial – https://www.clinicaltrials.gov/study/NCT03574597

BBC –https://www.bbc.co.uk/news/articles/cd188m73vn1o#:~:text=Obesity%20jabs%20could%20cut%20the,funded%20by%20a%20drug%20manufacturer

UCL – https://www.ucl.ac.uk/news/2024/may/weight-loss-drug-semaglutide-linked-better-heart-health

Follow us on @vytaclinic on Instagram to find out more!

Shopping Basket
Scroll to Top